Print
Email
Abaxis Inc. has a market cap of $607.1 million; its shares were traded at around $27.67 with a P/E ratio of 48.6 and P/S ratio of 4.2. Abaxis Inc. had an annual average earning growth of 32.8% over the past 10 years. GuruFocus rated Abaxis Inc. the business predictability rank of 3-star.
This is the insider trade history vs. stock price of ABAX. For the complete insider trading history of ABAX, click here.
Directors and Officers Recent Trades:
- Managing Director-Europe Achim Henkel sold 5,000 shares of ABAX stock on 11/15/2011 at the average price of 27.5. Achim Henkel owns at least 14,750 shares after this. The price of the stock has increased by 0.62% since.
- VP of Govt Affairs & Pac Rim Vladimir Ostoich sold 10,000 shares of ABAX stock on 10/28/2011 at the average price of 29.01. Vladimir Ostoich owns at least 382,313 shares after this. The price of the stock has decreased by 4.62% since.
- VP-Sales & Mktg, Animal Health Martin Mulroy sold 2,374 shares of ABAX stock on 10/26/2011 at the average price of 28.67. Martin Mulroy owns at least 24,765 shares after this. The price of the stock has decreased by 3.49% since.
- VP-Sales & Marketing,Medical Brenton Hanlon sold 4,000 shares of ABAX stock on 06/06/2011 at the average price of 28.27. Brenton Hanlon owns at least 6,033 shares after this. The price of the stock has decreased by 2.12% since.
For the complete insider trading history of ABAX, click here.
Subscribe RSS
